{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.text}}
Key takeaways
- Pharma and life sciences companies face a growing relevance gap in physician engagement.
- Successful CRM modernization requires a clear, future-focused commercial vision before investing in AI and new technology platforms.
- Pharma companies transitioning from legacy CRM systems should avoid simply replicating existing processes and instead use this opportunity to build adaptive, AI-driven commercial models aligned with the needs of tomorrow’s prescriber base.
- The evolving physician population includes several archetypes who require new engagement strategies that move beyond traditional rep outreach.
- Establish a new agentic AI front office vision before configuring technology to engage physicians of tomorrow.
The relevance gap
Pharmaceutical and life sciences companies are investing heavily in customer relationship management (CRM) modernization and artificial intelligence, and for good reason. While CRM systems change is required, many organizations are embracing this opportunity to address the performance gap of today’s customer engagement model:
- Pharma’s overall customer experience scores have dropped in trust, relevance, and simplicity.
- 82% of pharma executives believe their digital outreach is effective, while only 28% of healthcare professionals (HCPs) agree—with approximately 97% of digital outreach going unanswered.1
- More than 50% of accessible physicians now meet with only three or fewer pharma companies, meaning access has rebounded post pandemic but is increasingly concentrated among a small number of preferred partners.2
These challenges reflect a supply driven engagement model in which the front office decides when to engage with physicians, through what channel, and with what message. That logic made sense when physician access was relatively open and the pharma representative’s visit was the primary clinical information channel. Both conditions have shifted considerably, but the operating model underlying CRM and AI investment has been slower to follow.
Vision comes before technology for the CRM model
Without a clear new vision, technology alone cannot deliver ROI. The commercial leaders who can gain the most from CRM modernization and AI investment are not necessarily those with the most sophisticated platforms or the largest implementation budgets. They can be the ones who establish a clear vision of the commercial model they are building toward, remove existing organizational silos that may impede progress, and then configure technology to build toward the future vision. The question is not which AI to deploy or which CRM to choose. It is whether the commercial model being designed is truly aligned to the physician population it will need to serve tomorrow.
With Veeva CRM being phased out, moving to a new CRM tool is necessary. The potential risk lies in simply copying what you do today onto a new system. Instead, use this transition to design a smarter, future-ready front office that can support more advanced, AI-driven ways of working.
Avoiding the “lift-and-shift” trap in CRM
Most of the industry has begun their CRM journeys, many with the intent to address performance gaps with an elaborate vision of the customer engagement model of the future. Implementing the vision, however, remains elusive. Few life sciences companies report successfully scaling AI or seeing measurable financial impact. This gap is not a failure of technology; it is a failure in fully bringing the commercial organization together with an agentic front office approach and failing to recognize the shift in how customers should be segmented.
Building the agentic front office: The agentic front office should be a model in which AI agents handle routine, transactional, and time-sensitive elements of physician engagement, allowing human teams to focus where judgment, clinical depth, and institutional navigation truly matter. CRM is the enabling system of record. AI is the responsive operating intelligence. With AI, the customer engagement model can finally be built around the customer and not based on organizational silos. The problem: Most organizations are configuring CRM and AI around today’s engagement model, rather than the commercial model they will need as the physician population changes and AI capabilities shift over the next five years.
Who is actually in the doctor’s office—today and in five years
Any commercial vision should start with a realistic picture of the physician population it will serve, not just today, but when current investments have matured.
The physician prescriber base driving most commercial volume today skews significantly older than most digital engagement strategies assume.
- The average physician age in the United States is 51.2, and nearly half of active prescribers are 55 or older.3 That picture is changing rapidly. By the early 2030s, the baby boomer share of active prescribers will drop sharply from approximately 34% today to around 20% as the retirement wave accelerates.3
- Millennials and Gen Z will approach 40% of the prescriber workforce, and NP/PA prescribers will grow by roughly 40%, from approximately 350,000 to 490,000.4 The CRM and AI platforms being implemented today will still be in place when this transition is well underway.
The incoming prescriber base is more time-pressured and digitally native. More than 75% of physicians now work for hospitals, health systems, or corporate entities.5 For them, on-demand access to information is not a differentiator; it is table stakes. Commercial models enhanced for yesterday’s archetype will likely struggle to engage tomorrow’s providers.
The routing problem: Physician type comes before channel and message
Most commercial AI today segments physicians by how they prescribe. That’s useful for targeting but insufficient for engagement. The more important question is how physicians make decisions and what kind of interaction actually helps them. Engagement archetypes matter. Some physicians value independent evaluation of primary evidence and are better served through scientific access, not promotion. Others prioritize efficiency and want frictionless, self-service access to dosing, formulary, and patient support information, often without a rep interaction at all. Some move with peer networks, others with patient-specific constraints, and an increasing number operate within institutional decision structures that require engagement beyond the individual HCP.
Choose your archetype: How the agentic front office can enable physician engagement
In an agentic front office, AI agents handle interactions that can be resolved immediately and compliantly, things like answering clinical questions, surfacing formulary and access details, supporting patient assistance navigation, and detecting intent signals. Human roles are elevated—not replaced—and deployed where they add the most value.
Reps receive AI-generated pre-call intelligence so conversations are specific and relevant. MSLs engage with synthesized insight into a physician’s current scientific interests. Commercial teams track institutional decision-maker level—a dual-track that no current commercial model handles well.
To build this, the generational dimension is critical for sequencing investment. Archetypes include:
The Pragmatic Adopter: Today’s largest segment, well-served by traditional rep engagement, is disproportionately boomer and Gen X, individuals, and they’re approaching retirement.
The Efficiency Seeker and Institutional Gatekeeper: The archetypes least well served by existing commercial models are disproportionately millennial, Gen Z, and NP/PA.
An AI and CRM investment strategy based solely on today’s dominant user profile risks will become outdated, as the prescriber population is likely to change significantly by the time the investment fully matures.
The agentic front office serves provider archetypes of the future
With a clear picture of the physician population and its archetypes, the commercial platforms and AI sequencing starts to take shape.
In an agentic front office:
- An Efficiency Seeker queries a conversational AI agent at 9 p.m. for dosing information and gets an accurate, MLR-compliant answer in seconds with a prompt to connect with a rep for deeper discussion.
- A Peer Validator’s engagement is driven not by rep outreach but by AI that identifies key adopters in their reference network and activates those peer conversations.
- Before calling a Pragmatic Adopter, a rep receives an AI-generated briefing—patient mix, prescribing patterns, last interaction, formulary status—so the conversation is specific, relevant, and worth the physician’s time.
- An MSL engaging an Evidence Arbitrageur has AI-synthesized intelligence on that physician’s scientific interests and clinical questions, enabling a genuinely peer-level exchange.
- A commercial team tracking Institutional Gatekeepers uses AI to map formulary committee activity and clinical pathway decisions, because engaging physicians without institutional context produces limited results.
The commercial platform becomes the system of record for all of this. AI is the operating intelligence that makes it work. The archetype routing logic tells the system which type of engagement each physician needs. All three have to be in place for the model to function.
Building the agentic front office: What to prioritize now and what to architect for later
The buildout of an agentic front office is a staged investment across two horizons, not a single project.
Now: Build the foundation |
2027–2031: Build for the incoming prescriber base |
|---|---|
| Archetype classification: Dynamically classifying HCPs by how they engage, using CRM history, digital behavior, and content consumption is the single highest-leverage investment available. Every AI application performs better when it knows which archetype it is serving. This is the foundational layer most AI deployments are missing. | Agentic self-serve portals: Conversational AI agents giving Efficiency Seekers on-demand access to clinical evidence, dosing, patient support, and formulary data are the primary engagement surface for the fastest-growing archetype. The platform infrastructure exists. Organizational integration and content architecture are the work. |
| Pre-call intelligence: AI synthesizing prescribing trends, interaction history, patient mix, and formulary context into a rep briefing is one of the clearest near-term ROI opportunities in the CRM stack. | Institutional network mapping: AI modeling P&T committee membership, formulary decisions, and clinical pathway authorship is the capability the Institutional Gatekeeper archetype requires. As 75%+ of physicians move into large systems,5 individual HCP targeting without institutional context is increasingly insufficient. |
| Intent signal detection: Monitoring physician digital behavior as a leading indicator of engagement readiness moves the front office from scheduled outreach to demand-driven response. | NP/PA-specific engagement models: Calibrated to educational support and patient access navigation rather than promotional detailing serve a prescriber cohort growing 40%–45% over the next decade and currently underserved by most commercial AI strategies. |
| MLR-compliant content generation: GenAI producing specialty-specific variants from approved base claims enables the personalization the archetype model requires without overwhelming the review process. | Trust-indexed relationship scoring: Measuring relationship quality rather than call completion rates replaces the activity metrics driving most commercial dashboards with outcome metrics that actually predict long-term prescribing behavior. |
Key to a successful future
The commercial leaders who stand to benefit most from CRM modernization and AI aren’t those with the biggest budgets or most advanced systems, but those with a clear vision, who break down silos and align technology to support that vision. Success depends less on the platform chosen and more on how well the commercial model fits the physician population it targets.
With Veeva CRM being phased out, moving to a new CRM tool is necessary. The potential risk lies in simply copying what you do today onto a new system. Instead, use this transition to design a smarter, future-ready front office that can support more advanced, AI-driven ways of working.
{{filterContent.facetedTitle}}
{{contentList.loadingText}}
{{contentList.loadingText}}
Follow us
